跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 25,931 条关于
“BET inhibitor”
全部
25,931
临床试验
14,034
药物
4,792
机构
100
资讯
7,005
5个月前
BRD2 Emerges as Key Driver of BET Inhibitor Resistance Across Multiple Cancers
4个月前
Chinese BET Inhibitor NHWD-870 Receives Breakthrough Therapy Designation for Rare NUT Carcinoma
去年
Jacobio Pharma Receives IND Acceptance for BET Inhibitor JAB-8263 in Autoimmune Diseases
2年前
Why BET Inhibitors Fail in Estrogen-Driven Breast Cancer and How to Improve Them
去年
VYNE Therapeutics Advances VYN201 and VYN202 in Vitiligo and Psoriasis Trials
去年
VYNE Therapeutics' Repibresib Gel Fails to Meet Primary Endpoints in Phase 2b Vitiligo Trial
10个月前
Zenith Epigenetics' ZEN-3694 Receives FDA Orphan Drug Designation for NUT Carcinoma Treatment
23天前
BRD4 Targeted Therapies: Over 20 Candidates in Clinical Trials as Field Advances Toward Selectivity and Degradation
去年
Updates on Ruxolitinib Combinations for MPNs from ASH 2024
去年
VYN201 Shows Promise in Phase 1b Trial for Non-Segmental Vitiligo
第 1 页,共 701 页
上一页
下一页